Tetracycline-inducible packaging cell line for production of flavivirus replicon particles
about
High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.Translation of the Flavivirus Kunjin NS3 Gene in cis but Not Its RNA Sequence or Secondary Structure Is Essential for Efficient RNA PackagingConstruction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genesEssential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle AssemblyRole of Nonstructural Protein NS2A in Flavivirus AssemblyEfficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like ParticlesA trans-Complementing Recombination Trap Demonstrates a Low Propensity of Flaviviruses for Intermolecular RecombinationThe development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virusZika Virus Replicons for Drug DiscoveryDengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypesA Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in PatientsInhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteinsCharacterization of the mode of action of a potent dengue virus capsid inhibitorThe endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complexWest Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system.Flaviviral RNAs: weapons and targets in the war between virus and host.Assays for the identification of novel antivirals against bluetongue virus.Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus AssemblyA Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.Mosquito cell-derived West Nile virus replicon particles mimic arbovirus inoculum and have reduced spread in mice.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs.Flavivirus methyltransferase: a novel antiviral targettrans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors.Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.Virus-like particles in vaccine development.A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.Helicase Domain of West Nile Virus NS3 Protein Plays a Role in Inhibition of Type I Interferon Signalling.
P2860
Q27472764-7DF76E50-A772-459A-817A-1BDB8AEFF57EQ27477616-B53103DB-93F8-438B-AFC4-8B7368AF7264Q27485041-16C4884F-B4C8-42F1-A66A-F51DF40A1F0FQ27485487-8B1018B3-6723-4DDD-B987-DFB685A442B6Q27485896-12A0DC1D-C764-4ADA-AB8F-6EE8D9C1CED9Q27486405-F960B1E7-E4F9-42A7-96EA-E3E7965757C6Q27490533-E5A78DE7-9BA7-4557-9E89-0619BAD7A496Q27490779-8122FF64-5C74-4FE1-8EFE-F3ED8EF89A74Q27928069-60C29FB5-523F-4328-B9CC-676B736CBF52Q28742961-AA20C76D-AAD9-418F-A52E-4D1C39341687Q28954730-815E1BE4-4051-4F3A-AF05-DFFDC2C9FDC2Q29620712-50227AF9-7940-46C0-901F-499E9F2F67FAQ30365058-0CB4CD1D-9CB4-44B7-9817-182D7BDC76E0Q30484619-9F724AEE-BE3E-4125-9BF8-9DAEBEE2C79FQ33789772-E87D3469-34ED-4CE4-97E7-0D4101ADF422Q34432758-B08C549B-B68B-4046-9917-011177F6501BQ35022028-2B738A7C-AF36-4064-9BDF-5F5260D07165Q35300048-BD5ABC1D-A060-4523-998F-6CB26D79B020Q35914284-1561237B-0E18-4647-9FB4-251D597C9322Q36043170-4B7E077B-DD21-4D2B-AE7A-231FAE9E1C86Q36192685-2E532200-76B8-4B17-A034-66B2D71372FBQ36276928-93F0DD0B-DD8D-4372-8DDC-8BEC6980DE05Q36377208-0704B87C-4835-429C-AAC2-C3F298F3FA7EQ36937406-0BFB52A2-84AE-4B6D-ADFD-E9102DAB290AQ37197519-78DF3A75-6DCD-4C03-8F63-C1800EFA8B62Q37583440-AB8B8253-934D-4454-8E4A-BEB959CF8C32Q37596892-53435FC8-0426-47B1-86EA-B5249F309DCAQ37798008-C6C83E83-31FD-467B-B90C-A99AA3C912B8Q42983982-C21CD8B1-CFA5-41A6-B091-DCA72C8E54ACQ42998966-95FEA2AE-1BDC-4E60-A761-501D50984FF9Q43046851-C70F5BD4-B44E-4859-BA2F-01A9749065DB
P2860
Tetracycline-inducible packaging cell line for production of flavivirus replicon particles
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tetracycline-inducible packagi ...... flavivirus replicon particles
@ast
Tetracycline-inducible packagi ...... flavivirus replicon particles
@en
Tetracycline-inducible packagi ...... flavivirus replicon particles
@nl
type
label
Tetracycline-inducible packagi ...... flavivirus replicon particles
@ast
Tetracycline-inducible packagi ...... flavivirus replicon particles
@en
Tetracycline-inducible packagi ...... flavivirus replicon particles
@nl
prefLabel
Tetracycline-inducible packagi ...... flavivirus replicon particles
@ast
Tetracycline-inducible packagi ...... flavivirus replicon particles
@en
Tetracycline-inducible packagi ...... flavivirus replicon particles
@nl
P2093
P2860
P50
P1433
P1476
Tetracycline-inducible packagi ...... flavivirus replicon particles
@en
P2093
Andrew Davidson
Itaru Anraku
Michael Jacobs
Richard Linedale
Thuy T T Le
Wen Jun Liu
Xiang Ju Wang
P2860
P304
P356
10.1128/JVI.78.1.531-538.2004
P407
P577
2004-01-01T00:00:00Z